La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Phio Pharma a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Phio Pharma..

Phio Pharma (NASDAQ:PHIO) Azioni, Catena delle Opzioni

Phio Pharma

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul class="wp-block-list">
<li>Wells Fargo analyst Timur Braziler downgraded <strong>Columbia Banking System, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) from Overweight to Equal-Weight and lowered the price target from $29 to $27. Columbia Banking System shares closed at $25.07 on Wednesday. <a href="https://www.benzinga.com/quote/colb/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Erin Wright downgraded <strong>Molina Healthcare, Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) from Overweight to Equal-Weight and lowered the price target from $364 to $266. Molina Healthcare shares closed at $237.22 on Wednesday. <a href="https://www.benzinga.com/quote/moh/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Christine Cho downgraded the rating for <strong>The Cheesecake Factory Incorporate</strong>d (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) from Buy to Neutral but raised the price target from $66 to $67. Cheesecake Factory shares closed at $64.14 on Wednesday. <a href="https://www.benzinga.com/quote/vake/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen analyst Gautam Khanna downgraded <strong>Lockheed Martin Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) from Buy to Hold and cut the price target from $500 to $480. Lockheed Martin shares closed at $463.06 on Wednesday. <a href="https://www.benzinga.com/quote/lmt/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Mike Colonnese downgraded the rating for <strong>Coinbase Global, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) from Buy to Sell and slashed the price target from $305 to $300. Coinbase Global shares closed at $373.85 on Wednesday. <a href="https://www.benzinga.com/quote/coin/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying COIN stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/COIN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="603" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10101039/image-120-1024x603.png" alt="" class="wp-image-980194" style="width:637px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10101039/image-120-1024x603.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10101039/image-120-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10101039/image-120-768x453.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10101039/image-120.png 1103w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>Read This Next: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46316741/top-3-risk-off-stocks-that-may-rocket-higher-in-q3">Top 3 Risk Off Stocks That May Rocket Higher In Q3</a></strong> </li>
</ul>
<p>Photo via Shutterstock</p>


News

Downgrades

Markets

Analyst Ratings

Trading Ideas

CAKE

COIN

COLB

This Coinbase Global Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

<p><strong>United Airlines Holdings Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) and <strong>American Airlines Group Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) shares are climbing higher Thursday morning, drafting on the tailwinds of a strong <a href="https://www.benzinga.com/markets/earnings/25/07/46341383/delta-air-lines-ceo-confident-in-stronger-2025-as-demand-holds-steady">second-quarter</a> earnings report and optimistic forecast from industry leader <strong>Delta Air Lines Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>).</p>
<p><strong>What To Know:</strong> Delta&#8217;s stock surged early Thursday after the carrier announced stronger-than-expected second-quarter results, with <a href="https://www.benzinga.com/earnings">adjusted earnings</a> of $2.10 per share on operating revenue of $16.65 billion. The positive performance was fueled by a 26% jump in passenger revenue and continued strength in its premium and loyalty segments.</p>
<p>This strong showing from a major carrier like Delta often signals positive underlying trends for the entire airline industry. Investors anticipate that factors boosting Delta&#8217;s performance, such as resilient travel demand and stabilizing fuel costs, will likely benefit its competitors as well. Consequently, positive investor sentiment surrounding Delta has translated into sympathy gains for United and American.</p>
<p>Adding to the optimism, Delta reinstated its full-year 2025 guidance, projecting earnings per share between $5.25 and $6.25 and free cash flow of $3 billion to $4 billion. </p>
<p>This confident outlook suggests a sustained period of profitability and stability for the sector, causing investors on Thursday to buy into other major airlines ahead of their own upcoming earnings announcements.</p>
<p><strong>Benzinga Edge Rankings:</strong> Based on <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> rankings, UAL shows an exceptional score for Growth at 99.38, placing it among the top-rated stocks for this metric. The airline also boasts a strong Momentum score of 81.42, suggesting a powerful and sustained upward trend in its stock price.</p>
<p>Complementing this, UAL holds a solid Value score of 76.02, indicating that it is considered reasonably priced based on its financial fundamentals.</p>
<p>AAL presents a mixed financial profile. The airline&#8217;s most favorable metric is its respectable Growth score of 69.72. In contrast, its Value score is more moderate at 45.51, suggesting it is not considered a strong bargain. </p>
<p>The stock&#8217;s key weakness appears to be its Momentum, which is rated low at 20.61, indicating a lack of positive recent price movement.</p>
<p><strong>Price Action:</strong> According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, UAL shares are trading higher by 11.7% to $89.55 Thursday morning. AAL shares are meanwhile higher by 6.05% to $12.18.</p>
<p><strong>Read Also:</strong> <strong><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46204250/airline-stocks-face-flat-q2-but-1-thing-could-lift-them" target="_blank" rel="noreferrer noopener">Airline Stocks Face Flat Q2—But 1 Thing Could Lift Them</a></strong></p>
<h2 class="wp-block-heading">How To Buy UAL Stock</h2>
<p>By now you're likely curious about how to participate in the market for United Airlines Holdings &#8211; be it to purchase shares, or even attempt to bet against the company.</p>
<p>Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.</p>
<p>In the case of United Airlines Holdings, which is trading at $80.18 as of publishing time, $100 would buy you 1.25 shares of stock.</p>
<p>If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a>  Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.</p>
<p><em>Image: Shutterstock</em></p>


United Airlines, American Airlines Stocks Rise On Delta's Bullish Forecast

<p><strong>Plug Power Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares are moving lower Thursday after rallying more than 25% on Wednesday. Here&#8217;s a look at <a href="https://www.benzinga.com/markets/equities/25/07/46335049/wk-kellogg-nvidia-costco-plug-power-and-tesla-why-these-5-stocks-are-on-investors-radars-today">what&#8217;s going on</a>.</p>
<p><strong>What To Know:</strong> Plug Power has announced that it issued a warrant for the offer and sale of up to 31.5 million shares of common stock by Yorkville, the selling stockholder.</p>
<p>The warrant was issued pursuant to a secured debenture <a href="https://www.benzinga.com/news/earnings/25/04/45073201/plug-power-stock-is-trending-tuesday-whats-going-on">purchase agreement</a> dated April 28. The registration does not guarantee that any shares will be sold. Plug Power will not receive any proceeds from shares sold by the selling stockholder, but the company will receive proceeds related to any cash exercise of the warrant. Plug Power provided the update in a prospectus dated July 9.</p>
<p>The news comes after Plug shares ripped higher on Wednesday after the company <a href="https://www.benzinga.com/markets/small-cap/25/07/46318132/plug-power-extends-key-hydrogen-partnership-powering-future-growth-through-2030">announced</a> a new multi-year enhanced supply agreement with a leading U.S.-based industrial gas company and longtime hydrogen partner. The agreement extends the companies&#8217; strategic relationship through 2030.</p>
<p>&#8220;This expanded agreement supports our mission to build on our already robust and resilient hydrogen network in the U.S. As we continue to scale our applications business and build long-term partnerships with customers, reliable supply and cost efficiency are critical,&#8221; said <strong>Andy Marsh</strong>, CEO of Plug Power.</p>
<p>&#8220;This contract is a win for Plug, our customers, our suppliers and our margin profile. The immediate cost reduction complements our progress this year with&nbsp;Project Quantum Leap, focused on cost optimization and cash flow improvement.&#8221;</p>
<h3 class="wp-block-heading">How To Buy PLUG Stock</h3>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in Plug Power's case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<p><strong>PLUG Price Action:</strong> <a href="http://benzinga.com/quote/PLTR">Plug Power shares</a> were down 4.40% at $1.70 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/real-estate/25/07/46340278/i-would-disappear-politician-who-fled-communist-china-says-they-want-me-to-shut-up-about-chinas-soft-power-invasion-of-u-s-water-farml"><strong>&#8216;I Would Disappear&#8217;: Politician Who Fled Communist China Says &#8216;They Want Me To Shut Up&#8217; About China&#8217;s &#8216;Soft Power Invasion&#8217; of U.S. Water, Farmland</strong></a></li>
</ul>
<p><em>Photo: courtesy of Plug Power.</em></p>


Movers

PLUG

What's Going On With Plug Power Stock?

<p><a href="https://www.youtube.com/watch?v=K0UwLfevw24">https://www.youtube.com/watch?v=K0UwLfevw24</a></p>


Macro Notification

Politics

Economics

General

Fed's Musalem Says The Economy Is In A Good Place, With Labor Market At Or Near Full Employment; There Is Some Upside Risk To Inflation; There Have Been Some Positive Trends On Inflation In Recent Months, But The Outlook Is For It To Increase Going Forward Due To Tariffs

<p>Piper Sandler  analyst Thomas Champion   maintains Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Neutral and raises the price target from $65 to $84.</p>


Price Target

ROKU

Piper Sandler Maintains Neutral on Roku, Raises Price Target to $84

WIIM

Comstock Resources shares are trading lower after UBS downgraded the stock from Neutral to Sell.

<p><strong>Ultragenyx Pharmaceutical Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) and <strong>Mereo BioPharma Group plc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MREO#NASDAQ">MREO</a>) stocks are plunging on Thursday.</p>
<h2 class="wp-block-heading">What Happened?</h2>
<p>The companies on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis around the end of the year, consistent <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46331268/ultragenyx-and-mereo-biopharma-announce-ux143-phase-3-orbit-study-for-osteogenesis-imperfecta-prog" rel="noreferrer noopener">with the original plan</a>.</p>
<p>OI, also known as <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">brittle bone disease</a>, is a group of genetic disorders that make bones abnormally fragile and prone to fractures.</p>
<p><strong><em>Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/05/45655477/analyst-bullish-on-ultragenyx-poised-for-growth-with-six-drug-approvals-expected-by-2028" rel="noreferrer noopener">Analyst Bullish On Ultragenyx, Poised For Growth With Six Drug Approvals Expected By 2028</a></em></strong></p>
<p>William Blair noted that the update implies the second interim analysis did not meet the minimal p-value threshold of p&lt;0.01 to end the study early.</p>
<p>The Data Monitoring Committee (DMC) met and informed the company that UX143 demonstrates an acceptable safety profile, and the company should continue the study to the final analysis.</p>
<p>&#8220;While we had hoped to be able to stop the study early, we look forward to having results from both Orbit and Cosmic around the end of this year,&#8221; said <strong>Emil Kakkis</strong>, chief executive officer and president of Ultragenyx.</p>
<p>Consistent with the statistical analysis plan, data from the Cosmic study were not analyzed at this interim time point. The study is going well, and safety in this younger patient population is consistent with the safety profile of the other studies.</p>
<p>Patients will continue dosing in the ongoing Phase 3 Orbit and Cosmic clinical studies. The final analyses will be conducted after patients have been on therapy for at least 18 months.</p>
<p>The threshold for the Phase 3 Orbit final analysis is p&lt;0.04, and for the Phase 3 Cosmic final analysis is p&lt;0.05.</p>
<h2 class="wp-block-heading">Analyst&#8217;s Take</h2>
<p>William Blair acknowledged the disappointment that the Orbit study didn&#8217;t achieve statistical significance at the second interim analysis. However, they believe the market&#8217;s reaction is severely overdone. They anticipate a high likelihood of a positive outcome from the final analysis in the fourth quarter, citing the longer follow-up duration and a lower statistical significance threshold.</p>
<p>Analyst Sami Corwin from William Blair reiterated, &#8220;We continue to believe that the Phase II Orbit data support setrusumab as a clinically active molecule in OI, and we do not think this update impacts the top-line analyses&#8217; probability of success.&#8221;</p>
<p><strong>Price Action: </strong>RARE stock is trading lower by 26.2% to $30.60, and MREO stock is down 34.7% at $1.919 at last check Thursday.</p>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><strong><em><a href="https://www.benzinga.com/markets/tech/25/07/46342110/amazon-unveils-powerful-new-ai-servers-to-support-nvidias-most-advanced-chips" target="_blank" rel="noreferrer noopener">Amazon Unveils Powerful New AI Servers To Support Nvidia&#8217;s Most Advanced Chips</a></em></strong></li>
</ul>
<p><em>Photo via Shutterstock</em></p>


Analyst Color

Biotech

Health Care

MREO

RARE

Ultragenyx, Mereo Shares Dive As Brittle Bone Disease Drug Misses Early Win

SLNO

Soleno Therapeutics shares are trading lower after the company provided Q2 preliminary results and announced a $200 million public offering.

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul class="wp-block-list">
<li>Mizuho analyst Peter Costa initiated coverage on <strong>Napco Security Technologies, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) with an Outperform rating and announced a price target of $39. NAPCO Security shares closed at $30.20 on Wednesday. <a href="https://www.benzinga.com/quote/NSSC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Seaport Global analyst Tom Curran initiated coverage on <strong>GE Vernova Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Buy rating and announced a price target of $630. GE Vernova shares closed at $535.77 on Wednesday. <a href="https://www.benzinga.com/quote/GEV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst James Schneider initiated coverage on <strong>NVIDIA Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy rating and announced a price target of $185. Nvidia shares closed at $162.88 on Wednesday. <a href="https://www.benzinga.com/quote/NVDA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Toshiya Hari initiated coverage on Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) with a Buy rating and announced a price target of $115. Lam Research shares closed at $99.81 on Wednesday. <a href="https://www.benzinga.com/quote/lrcx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst Daniel Jester initiated coverage on <strong>Automatic Data Processing, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) with a Market Perform rating and announced a price target of $340. Automatic Data Processing shares closed at $308.41 on Wednesday. <a href="https://www.benzinga.com/quote/adp/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying NVDA stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10100351/image-119-1024x586.png" alt="" class="wp-image-980181" style="width:622px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10100351/image-119-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10100351/image-119-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10100351/image-119-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10100351/image-119.png 1127w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46316741/top-3-risk-off-stocks-that-may-rocket-higher-in-q3">Top 3 Risk Off Stocks That May Rocket Higher In Q3</a></strong> </li>
</ul>
<p>Photo via Shutterstock</p>


Initiation

LRCX

NSSC

NVDA

This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

<p>Piper Sandler  analyst Ryan Todd   maintains Marathon Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) with a Neutral and raises the price target from $157 to $175.</p>


Piper Sandler Maintains Neutral on Marathon Petroleum, Raises Price Target to $175

NTHI

NTHI stock has given up its prior gain. NeOnc Technologies Holdings shares were trading higher after the company announced its board approved a $50 million strategic partnership with Quazar Investment.

WDAY

Workday shares are trading lower after Piper Sandler downgraded the stock from Neutral to Underweight and cut its price target from $255 to $235.

<p>Art's-Way Manufacturing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTW#NASDAQ">ARTW</a>) reported quarterly earnings of $0.29 per share.  The company reported $6.337 million in sales this quarter. This is a 5.84 percent decrease over sales of $6.730 million the same period last year.</p>


Earnings

ARTW

Art's-Way Manufacturing Q2 EPS $0.29, Sales $6.337M Down From $6.730M YoY

CRWV

CoreWeave shares are trading lower after Needham downgraded the stock from Buy to Hold.

<p>High-rolling investors have positioned themselves bullish on United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in UAL often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 18 options trades for United Airlines Holdings. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 61% bullish and 22% bearish. Among all the options we identified, there was one put, amounting to $27,376, and 17 calls, totaling $1,253,840.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $52.5 to $120.0 for United Airlines Holdings during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for United Airlines Holdings's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of United Airlines Holdings's whale activity within a strike price range from $52.5 to $120.0 in the last 30 days. </p>
<h3>United Airlines Holdings Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752156077_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$8.9</td>
<td>$7.95</td>
<td>$7.95</td>
<td>$81.00</td>
<td>$190.0K</td>
<td>158</td>
<td>270</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$37.95</td>
<td>$36.35</td>
<td>$37.29</td>
<td>$52.50</td>
<td>$186.4K</td>
<td>428</td>
<td>0</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$2.12</td>
<td>$1.11</td>
<td>$2.12</td>
<td>$87.00</td>
<td>$158.1K</td>
<td>4.8K</td>
<td>5.0K</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$6.7</td>
<td>$6.3</td>
<td>$6.7</td>
<td>$120.00</td>
<td>$103.8K</td>
<td>926</td>
<td>211</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$5.5</td>
<td>$5.35</td>
<td>$5.35</td>
<td>$85.00</td>
<td>$80.2K</td>
<td>3.3K</td>
<td>378</td>
</tr>
</tbody>
</table>
</p>
<h3>About United Airlines Holdings</h3>
<p>United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel than its large US peers.</p>
<h3>United Airlines Holdings's Current Market Status</h3>
<ul>
<li>With a trading volume of 3,085,981, the price of UAL is up by 9.28%, reaching $87.62.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 6 days from now.</li>
</ul>
<h3>What Analysts Are Saying About United Airlines Holdings</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $103.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for United Airlines Holdings, targeting a price of $103. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for United Airlines Holdings with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

United Airlines Holdings Unusual Options Activity For July 10

<p>Ratings for Comstock Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRK#NYSE">CRK</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.29, a high estimate of $34.00, and a low estimate of $12.00. This upward trend is apparent, with the current average reflecting a 23.88% increase from the previous average price target of $18.80.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752156073_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>A clear picture of Comstock Resources's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peyton Dorne</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$20.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Doug Leggate</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$34.00</td>
<td>-</td>
</tr>
<tr>
<td>Paul Diamond</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$27.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Kalei Akamine</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$27.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Underweight</td>
<td>$12.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Peyton Dorne</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$19.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Comstock Resources. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Comstock Resources compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Comstock Resources's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Comstock Resources's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CRK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Comstock Resources analyst ratings.</strong></a></p>
<h2>Get to Know Comstock Resources Better</h2>
<p>Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. Its oil and gas operations are concentrated in Louisiana and Texas.</p>
<h3>Comstock Resources: A Financial Overview</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Comstock Resources's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>52.74%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Comstock Resources's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-23.65%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Comstock Resources's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-5.56%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Comstock Resources's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-1.87%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>1.49</strong>, Comstock Resources faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Where Comstock Resources Stands With Analysts

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Palantir Technologies</strong>.</p>
<p>Looking at options history for Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) we detected 14 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish expectations and 21% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $64,860 and 12, calls, for a total amount of $716,855.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $150.0 for Palantir Technologies during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Palantir Technologies's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Palantir Technologies's significant trades, within a strike price range of $50.0 to $150.0, over the past month.</p>
<h3>Palantir Technologies Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752156072_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$11.0</td>
<td>$10.95</td>
<td>$10.95</td>
<td>$134.00</td>
<td>$164.3K</td>
<td>2.4K</td>
<td>319</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$4.4</td>
<td>$4.3</td>
<td>$4.35</td>
<td>$145.00</td>
<td>$86.5K</td>
<td>20.2K</td>
<td>1.5K</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$15.25</td>
<td>$15.05</td>
<td>$15.25</td>
<td>$140.00</td>
<td>$76.2K</td>
<td>8.5K</td>
<td>190</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$8.1</td>
<td>$7.95</td>
<td>$8.15</td>
<td>$140.00</td>
<td>$73.3K</td>
<td>19.1K</td>
<td>624</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$5.65</td>
<td>$5.6</td>
<td>$5.65</td>
<td>$142.00</td>
<td>$56.5K</td>
<td>2.4K</td>
<td>473</td>
</tr>
</tbody>
</table>
</p>
<h3>About Palantir Technologies</h3>
<p>Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.</p>
<p>Following our analysis of the options activities associated with Palantir Technologies, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Palantir Technologies Standing Right Now?</h3>
<ul>
<li>With a trading volume of 8,458,948, the price of PLTR is up by 1.25%, reaching $144.92.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 25 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Palantir Technologies</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $135.5.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Underperform rating for Palantir Technologies, targeting a price of $116.<br />
&#x2A; An analyst from Loop Capital has decided to maintain their Buy rating on Palantir Technologies, which currently sits at a price target of $155. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Palantir Technologies options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


PLTR

This Is What Whales Are Betting On Palantir Technologies

<p>High-rolling investors have positioned themselves bullish on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CLS often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 8 options trades for Celestica. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 37% bullish and 37% bearish. Among all the options we identified, there was one put, amounting to $40,000, and 7 calls, totaling $448,435.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $87.5 to $162.5 for Celestica over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Celestica's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Celestica's whale trades within a strike price range from $87.5 to $162.5 in the last 30 days. </p>
<h3>Celestica Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752156067_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$78.5</td>
<td>$75.7</td>
<td>$76.51</td>
<td>$87.50</td>
<td>$76.5K</td>
<td align="right">295</td>
<td align="right">0</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$77.1</td>
<td>$74.2</td>
<td>$76.21</td>
<td>$92.50</td>
<td>$76.2K</td>
<td align="right">14</td>
<td align="right">10</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/25/25</td>
<td>$7.6</td>
<td>$6.4</td>
<td>$7.0</td>
<td>$162.50</td>
<td>$70.0K</td>
<td align="right">10</td>
<td align="right">100</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$34.5</td>
<td>$33.4</td>
<td>$33.95</td>
<td>$130.00</td>
<td>$67.9K</td>
<td align="right">528</td>
<td align="right">0</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$11.0</td>
<td>$9.1</td>
<td>$10.55</td>
<td>$152.50</td>
<td>$58.0K</td>
<td align="right">284</td>
<td align="right">55</td>
</tr>
</tbody>
</table>
</p>
<h3>About Celestica</h3>
<p>Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.</p>
<p>After a thorough review of the options trading surrounding Celestica, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Celestica</h3>
<ul>
<li>With a trading volume of 242,712, the price of CLS is up by 0.99%, reaching $162.5.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 18 days from now.</li>
</ul>
<h3>What The Experts Say On Celestica</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $146.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Celestica with a target price of $146. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Celestica options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


This Is What Whales Are Betting On Celestica

ABVE

Above Food Ingredients shares are trading higher on continued strength following its merger agreement with Palm Global on Monday.

<p>Analysts' ratings for Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $27.4, with a high estimate of $30.00 and a low estimate of $26.00. This current average has decreased by 0.36% from the previous average price target of $27.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752156056_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>A comprehensive examination of how financial experts perceive Associated Banc is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>David Smith</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Hold</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Terry McEvoy</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$27.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Associated Banc. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Associated Banc compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Associated Banc's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>For valuable insights into Associated Banc's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ASB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Associated Banc analyst ratings.</strong></a></p>
<h2>Delving into Associated Banc's Background</h2>
<p>Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.</p>
<h3>Financial Insights: Associated Banc</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Associated Banc showcased positive performance, achieving a revenue growth rate of <strong>6.63%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>28.88%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>2.22%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Associated Banc's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.23%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Associated Banc's debt-to-equity ratio surpasses industry norms, standing at <strong>0.58</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Outlook: Associated Banc Through The Eyes Of 5 Analysts

Press Releases

American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting

Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update

Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort

Comments

Phio Pharma

Phio Pharma (PHIO) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO